13G Filing: Sabby Capital Opens Large Position in Rexahn Pharmaceuticals, Inc. (RNN)
Hal Mintz's Sabby Capital has revealed a new position in Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) through a 13G filing with the SEC.
Posts Tagged ‘Sabby Capital’
3 Stocks Hedge Funds Just Bought; Should You?
We have a trifecta of recent hedge fund buying activity for you to digest, featuring three different funds and three different stocks.
Aegerion Pharmaceuticals Inc. (AEGR), Cytori Therapeutics Inc (CYTX): Scopia Capital and Sabby Capital Are Bullish on These Stocks
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) continues to feel hedge funds’ bullishness.
Aastrom Biosciences Inc (ASTM), The Providence Service Corporation (PRSC): Sabby Capital’s & Coliseum Capital’s Latest Moves
In two different filings with the U.S.
Hal Mintz And Sabby Capital Disclose New Investments In StemCells Inc (STEM) And Skystar Bio-Pharmaceutical Company (SKBI)
Hal Mintz, the manager of Sabby Capital, believes StemCells Inc (NASDAQ:STEM) is a good investment and has opened a position for his fund.
Sabby Capital Reveals New 7.3% Stake In RiceBran Technologies (RIBT)
RiceBran Technologies (NASDAQ:RIBT) has caught the attention of Hal Mintz, who has initiated a new position.
Adage Capital Management Discloses New Stake in OvaScience Inc (OVAS)
A new filing with the SEC shows that Phill Gross and Robert Atchinson's Adage Capital Management has initiated a stake in OvaScience Inc (NASDAQ:OVAS).
Deerfield Management Boosts Its Stake in OvaScience Inc (OVAS)
Deerfield Management, led by James E.
Kevin Kotler’s Broadfin Capital Reports New Stake In MELA Sciences Inc (MELA)
Kevin Kotler’s Broadfin Capital, in its latest filing with the Securities and Exchange Commission, has reported ownership of 9.09 million shares of MELA Sciences Inc (NASDAQ...
